Undervalued Stocks
INMD is currently part of our Undervalued Stocks screen, meaning it meets strict valuation and quality criteria
INMODE LTD (INMD) Stock Price & Overview
NASDAQ:INMD • IL0011595993
Current stock price
13.79 USD
+0.09 (+0.66%)
At close:
13.79 USD
0 (0%)
After Hours:
The current stock price of INMD is 13.79 USD. Today INMD is up by 0.66%. In the past month the price increased by 2.53%. In the past year, price decreased by -12.22%.
INMD Key Statistics
52-Week Range12.72 - 16.74
Current INMD stock price positioned within its 52-week range.
1-Month Range12.72 - 13.8943
Current INMD stock price positioned within its 1-month range.
- Market Cap
- 873.734M
- P/E
- 8.51
- Fwd P/E
- 9.35
- EPS (TTM)
- 1.62
- Dividend Yield
- N/A
INMD Stock Performance
Today
+0.66%
1 Week
+0.29%
1 Month
+2.53%
3 Months
-6.82%
Longer-term
6 Months -8.98%
1 Year -12.22%
2 Years -19.78%
3 Years -62.99%
5 Years -68.05%
10 Years N/A
INMD Stock Chart
INMD Stock Screens
INMD currently appears in the following ChartMill screener lists.
High Free Cash Flow Stocks
INMD is currently part of our High Free Cash Flow Stocks screen, indicating it generates strong cash flows relative to its price.
Low P/E Stocks
INMD is currently part of our Low P/E Stocks screen, indicating it cheap while it also meets financial health criteria.
Value Stocks with Strong Balance Sheets
INMD is currently part of our value stocks with Strong Balance Sheets screen, indicating it cheap while meeting strict financial health and debt criteria.
INMD Technical Analysis
ChartMill assigns a technical rating of 1 / 10 to INMD. When comparing the yearly performance of all stocks, INMD is a bad performer in the overall market: 79.4% of all stocks are doing better.
Chartmill TA Rating
Chartmill Setup Rating
INMD Fundamental Analysis
ChartMill assigns a fundamental rating of 7 / 10 to INMD. Both the health and profitability get an excellent rating, making INMD a very profitable company, without any liquidiy or solvency issues.
Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend
INMD Earnings
On February 10, 2026 INMD reported an EPS of 0.46 and a revenue of 103.85M. The company beat EPS expectations (8.04% surprise) and missed revenue expectations (-2.48% surprise).
Next Earnings DateApr 27, 2026
Last Earnings DateFeb 10, 2026
PeriodQ4 / 2025
EPS Reported$0.46
Revenue Reported103.854M
EPS Surprise 8.04%
Revenue Surprise -2.48%
INMD Forecast & Estimates
13 analysts have analysed INMD and the average price target is 17.14 USD. This implies a price increase of 24.26% is expected in the next year compared to the current price of 13.79.
For the next year, analysts expect an EPS growth of -8.96% and a revenue growth -0.36% for INMD
Analysts
Analysts75.38
Price Target17.14 (24.29%)
EPS Next Y-8.96%
Revenue Next Year-0.36%
INMD Groups
Sector & Classification
INMD Financial Highlights
Over the last trailing twelve months INMD reported a non-GAAP Earnings per Share(EPS) of 1.62. The EPS decreased by -8.99% compared to the year before.
Income Statements
Revenue(TTM)370.50M
Net Income(TTM)93.83M
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 25.33% | ||
| ROA | 12.24% | ||
| ROE | 13.73% | ||
| Debt/Equity | 0 |
Chartmill High Growth Momentum
EPS Q2Q%9.52%
Sales Q2Q%6.13%
EPS 1Y (TTM)-8.99%
Revenue 1Y (TTM)-6.16%
INMD Ownership
Ownership
Inst Owners56.66%
Shares63.36M
Float56.16M
Ins Owners10.65%
Short Float %5.88%
Short Ratio2.74
INMD Competitors/Peers
The largest stocks on the US markets in the "Health Care Equipment" sub-industry
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 17.91 | 178.754B | ||
| ISRG | INTUITIVE SURGICAL INC | 44.23 | 160.562B | ||
| SYK | STRYKER CORP | 21.92 | 126.877B | ||
| BSX | BOSTON SCIENTIFIC CORP | 17.96 | 93.218B | ||
| EW | EDWARDS LIFESCIENCES CORP | 26.9 | 47.074B | ||
| IDXX | IDEXX LABORATORIES INC | 38.42 | 45.348B | ||
| BDX | BECTON DICKINSON AND CO | 11.33 | 43.995B | ||
| RMD | RESMED INC | 18.25 | 32.645B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 13.61 | 32.062B | ||
| DXCM | DEXCOM INC | 24.47 | 23.946B | ||
| ZBH | ZIMMER BIOMET HOLDINGS INC | 10.72 | 17.783B | ||
| HOLX | HOLOGIC INC | 15.41 | 16.888B | ||
| PODD | INSULET CORP | 31.6 | 14.383B |
Related stock screener links
View all stocks in the Health Care Equipment Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About INMD
Company Profile
InMode Ltd. designs, develops, manufactures and markets minimally-invasive aesthetic medical products. Company's products and solutions are primarily designed to address three energy-based treatment categories comprised of: face and body contouring; medical aesthetics; and women’s health. The firm have developed and commercialized products utilizing medically-accepted RF energy technology, which can penetrate deep into the subdermal fat, allowing adipose tissue remodeling. It's RF energy-based proprietary technologies - Radio Frequency Assisted Lipolysis (RFAL), Deep Subdermal Fractional RF, Simultaneous Fat Destruction and Skin Tightening and Deep Heating Collagen Remodeling for skin and human natural openings- represent a paradigm shift in the minimally-invasive aesthetic solutions market. These technologies are used by physicians to remodel subdermal adipose, or fatty tissue in a variety of procedures.
Company Info
IPO: 2019-08-08
INMODE LTD
Tavor Building, Sha'ar Yokneam, Pob 533
Yokneam 2069200 IL
CEO: Moshe Mizrahy
Employees: 660
Phone: 97249097470
INMODE LTD / INMD FAQ
Can you describe the business of INMODE LTD?
InMode Ltd. designs, develops, manufactures and markets minimally-invasive aesthetic medical products. Company's products and solutions are primarily designed to address three energy-based treatment categories comprised of: face and body contouring; medical aesthetics; and women’s health. The firm have developed and commercialized products utilizing medically-accepted RF energy technology, which can penetrate deep into the subdermal fat, allowing adipose tissue remodeling. It's RF energy-based proprietary technologies - Radio Frequency Assisted Lipolysis (RFAL), Deep Subdermal Fractional RF, Simultaneous Fat Destruction and Skin Tightening and Deep Heating Collagen Remodeling for skin and human natural openings- represent a paradigm shift in the minimally-invasive aesthetic solutions market. These technologies are used by physicians to remodel subdermal adipose, or fatty tissue in a variety of procedures.
Can you provide the latest stock price for INMODE LTD?
The current stock price of INMD is 13.79 USD. The price increased by 0.66% in the last trading session.
What is the dividend status of INMODE LTD?
INMD does not pay a dividend.
What is the ChartMill technical and fundamental rating of INMD stock?
INMD has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 7 out of 10.
How is the market expecting INMD stock to perform?
13 analysts have analysed INMD and the average price target is 17.14 USD. This implies a price increase of 24.26% is expected in the next year compared to the current price of 13.79.
What is the next earnings date for INMD stock?
INMODE LTD (INMD) will report earnings on 2026-04-27, before the market open.